Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development

Go back to Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
(NASDAQ: ENVB) Delayed: 1.48 +0.02 (1.37%)
Previous Close $1.46    52 Week High $ 
Open $1.51    52 Week Low $ 
Day High $1.53    P/E N/A 
Day Low $1.46    EPS $ 
Volume 72,978